thiazolidines has been researched along with Liver Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, F; Cheng, X; Hu, Y; Rao, J; Shen, G; Wang, X; Yang, C; Yang, S | 1 |
| Emoto, C; Nakamaru, Y; Shimizu, M; Yamazaki, H | 1 |
| Dingemanse, J; Guérard, N; Hoch, M; Zwingelstein, C | 1 |
| Faisst, N; Halabi, A; Hinrichsen, H; Maatouk, H; Siegler, KE | 1 |
| Gonzalez, FJ; Isom, HC; Kang, BH; Kennett, MJ; McDevitt, EI; Murray, IA; Palkar, PS; Perdew, GH; Peters, JM; Shan, W | 1 |
| CAROLI, J; JULIEN, C | 1 |
| Cohen, SD; Dominick, PK; Roberts, JC; Slitt, AM | 1 |
| Fleming, JF; Miquel, J; Weber, HU | 1 |
| Della Lunga, S; Marulli, R; Rapex, G; Rapino, P; Sabatino, P | 1 |
| Raymond, N | 1 |
| Bartsch, H; Brouet, I; Calmels, S; Ohshima, H; Wu, Y | 1 |
| Rommelspacher, H; Wlodek, L | 1 |
| Bradford, BU; Brenner, D; Enomoto, N; Forman, D; Frey, W; Iimuro, Y; Kono, H; Nakagami, M; Rusyn, I; Thurman, RG; Yamashina, S | 1 |
| Saigot, T | 1 |
| Huang, HS; Jurima-Romet, M | 1 |
1 review(s) available for thiazolidines and Liver Diseases
| Article | Year |
|---|---|
Thiazolidine-4-carboxylic acid, a physiologic sulfhydryl antioxidant with potential value in geriatric medicine.
Topics: Aged; Animals; Antioxidants; Chemical Phenomena; Chemistry; Cysteine; Dogs; Drug Combinations; Folic Acid; Gastrointestinal Diseases; Humans; Liver Diseases; Longevity; Mice; Rats; Thiazoles; Thiazolidines | 1982 |
3 trial(s) available for thiazolidines and Liver Diseases
| Article | Year |
|---|---|
Human pharmacokinetic profiling of the dipeptidyl peptidase-IV inhibitor teneligliptin using physiologically based pharmacokinetic modeling.
Topics: Adult; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dipeptidyl-Peptidase IV Inhibitors; Drug Interactions; Female; Humans; Intestinal Mucosa; Ketoconazole; Liver; Liver Diseases; Male; Middle Aged; Models, Biological; Pyrazoles; Renal Insufficiency; Reproducibility of Results; Thiazolidines; Young Adult | 2015 |
Effect of Hepatic or Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Ponesimod, a Selective S1P1 Receptor Modulator.
Topics: Adult; Area Under Curve; Case-Control Studies; Female; Humans; Liver Diseases; Male; Middle Aged; Receptors, Lysosphingolipid; Renal Insufficiency; Severity of Illness Index; Thiazoles; Thiazolidines | 2016 |
Pharmacokinetics and safety of teneligliptin in subjects with hepatic impairment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Area Under Curve; Dipeptidyl-Peptidase IV Inhibitors; Drug Monitoring; Female; Humans; Least-Squares Analysis; Liver; Liver Diseases; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Pyrazoles; Risk Assessment; Severity of Illness Index; Thiazolidines; Young Adult | 2014 |
11 other study(ies) available for thiazolidines and Liver Diseases
| Article | Year |
|---|---|
Hyperglycemia-Triggered Sphingosine-1-Phosphate and Sphingosine-1-Phosphate Receptor 3 Signaling Worsens Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization.
Topics: Aged; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Female; Humans; Hyperglycemia; Liver; Liver Diseases; Liver Transplantation; Lysophospholipids; Macrophages; Male; Mice; Middle Aged; Reperfusion Injury; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Streptozocin; Thiazolidines | 2019 |
Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
Topics: Animals; Biomarkers; Carbon Tetrachloride; Cell Proliferation; Cells, Cultured; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Inflammation Mediators; Ligands; Liver; Liver Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; PPAR delta; PPAR-beta; Protective Agents; Thiazolidines; Time Factors; Tumor Necrosis Factor-alpha | 2008 |
[THERAPEUTIC ACTION OF THIAZOLIDINE-CARBOXYLIC ACID IN HEPATOLOGY].
Topics: Carboxylic Acids; Gastroenterology; Humans; Lipotropic Agents; Liver Diseases; Thiazoles; Thiazolidines | 1965 |
Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Topics: Acetaminophen; Animals; Blood Urea Nitrogen; Buthionine Sulfoximine; Chemical and Drug Induced Liver Injury; Cysteine; Glutathione; In Vitro Techniques; Kidney; Kidney Diseases; L-Iditol 2-Dehydrogenase; Liver; Liver Diseases; Male; Mice; Mice, Inbred Strains; Microsomes, Liver; Prodrugs; Protective Agents; Thiazoles; Thiazolidines | 2005 |
[Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
Topics: Adult; Aged; Arginine; Fatty Liver; Female; Hepatitis; Humans; Liver; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Thiazolidines; Uridine Diphosphate Glucose | 1982 |
[Value of the use of a new hepatotropic drug, arginine tidiacicate in gastroenterology. Results of a multicentric study].
Topics: Adult; Aged; Arginine; Female; Gastrointestinal Diseases; Humans; Liver Diseases; Male; Middle Aged; Thiazoles; Thiazolidines | 1981 |
Increased endogenous N-nitrosamine and nitrate formation by induction of nitric oxide synthase in rats with acute hepatic injury caused by Propionibacterium acnes and lipopolysaccharide administration.
Topics: Amino Acid Oxidoreductases; Animals; Disease Models, Animal; Enzyme Induction; Lipopolysaccharides; Liver Diseases; Male; Necrosis; Nitrates; Nitric Oxide Synthase; Nitrosamines; Nitroso Compounds; Propionibacterium acnes; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines | 1993 |
2-Methyl-thiazolidine-2,4-dicarboxylic acid as prodrug of L-cysteine. Protection against paracetamol hepatotoxicity in mice.
Topics: Acetaminophen; Animals; Antidotes; Chemical and Drug Induced Liver Injury; Glutathione; Liver; Liver Diseases; Liver Function Tests; Male; Mice; Oxidative Stress; Prodrugs; Thiazoles; Thiazolidines | 1997 |
The glutathione precursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat.
Topics: Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Ethanol; Glutathione; Intubation, Gastrointestinal; Kupffer Cells; Liver; Liver Diseases; Male; Necrosis; NF-kappa B; Prodrugs; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; RNA, Messenger; Thiazoles; Thiazolidines; Time Factors; Tumor Necrosis Factor-alpha | 2000 |
[Value of tiadilon in hepatobiliary pathology].
Topics: Adult; Aged; Alcoholic Intoxication; Arginine; Asthenia; Dietary Fats; Female; Hepatitis, Viral, Human; Humans; Liver Diseases; Male; Middle Aged; Thiazoles; Thiazolidines | 1979 |
Enalapril hepatotoxicity in the rat. Effects of modulators of cytochrome P450 and glutathione.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Biotransformation; Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Enalapril; Enzyme Induction; Glutathione; Inactivation, Metabolic; Liver; Liver Diseases; Male; Necrosis; Pregnenolone Carbonitrile; Protoporphyrins; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred F344; Sulfhydryl Compounds; Thiazoles; Thiazolidines | 1992 |